TyG Index novel Prognostic Indicator in CKD Patients, reveals research
Researchers have found in a new study that a high TyG index predicts poor clinical outcomes and may serve as a novel prognostic indicator in CKD patients. However, further studies are needed to validate these findings.
A study was done to identify the relationship of triglyceride-glucose (TyG) index with clinical outcomes in chronic kidney disease (CKD) patients based on current available evidence. PubMed, EMBASE, Web of Science and CNKI databases were searched up to August 31, 2024.
Primary outcome was the all-cause mortality. Secondary outcomes included the coronary artery disease (CAD) mortality, CKD progression, risk of severe coronary artery stenosis (SCAS), major adverse cardiovascular event (MACE), coronary artery calcification (CAC) progression, end-stage renal disease (ESRD), and nonalcoholic fatty liver disease (NAFLD). The hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI) were combined to assess the predictive role of TyG index for above clinical outcomes among CKD patients. All statistical analysis was performed by STATA 15.0 version. Results: Twelve studies with 26,530 cases were included.
Pooled results indicated that elevated TyG index was significantly related to increased risk for all-cause mortality (HR = 1.22, 95% CI: 1.13–1.31, P<0.001). Besides, high TyG index was also associated with the CAD mortality (HR = 1.19, 95% CI: 1.04–1.36, P = 0.011), occurrence of CKD progression (HR = 1.52, 95% CI: 1.36–1.70, P<0.001), SCAS (OR = 1.79, 95% CI: 1.13–2.83, P = 0.013), MACE (OR = 1.68, 95% CI: 1.11–2.54, P = 0.014), CAC progression (OR = 1.55, 95% CI: 1.06–1.76, P = 0.02), CAD (OR = 2.865, 95% CI: 1.681–4.885, P<0.001), ESRD (OR = 1.49, 95% CI: 1.12–1.99, P = 0.006) and NAFLD (OR = 4.903, 95% CI: 3.046–7.893, P<0.001). High TyG index predicts poor clinical outcomes and might serve as a novel prognostic indicator among CKD patients. However, more studies are still needed to verify above findings.
Reference:
Tuo, J., Li, Z. & Xie, L. Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: a meta-analysis. BMC Nephrol 26, 61 (2025). https://doi.org/10.1186/s12882-025-03984-w
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.